Birte Elias-Hamp

480 total citations
9 papers, 310 citations indexed

About

Birte Elias-Hamp is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Birte Elias-Hamp has authored 9 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Birte Elias-Hamp's work include Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Birte Elias-Hamp is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Birte Elias-Hamp collaborates with scholars based in Germany, United States and Switzerland. Birte Elias-Hamp's co-authors include Ralf Gold, Annette Langer‐Gould, Aiden Haghikia, Kerstin Hellwig, Sandra Herbstritt, Nadja Borisow, Martin Marziniak, Tobias Tenenbaum, Tania Kümpfel and Henriette Schneider and has published in prestigious journals such as JAMA Neurology, Neurotherapeutics and Frontiers in Neurology.

In The Last Decade

Birte Elias-Hamp

7 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birte Elias-Hamp Germany 5 216 166 110 75 29 9 310
Maurice Dahdaleh Saudi Arabia 11 230 1.1× 48 0.3× 31 0.3× 55 0.7× 7 0.2× 16 285
Ai‐Lan Nguyen Australia 9 107 0.5× 59 0.4× 26 0.2× 27 0.4× 10 0.3× 17 158
Hanna Joensen Denmark 6 234 1.1× 27 0.2× 37 0.3× 73 1.0× 7 0.2× 7 251
Licínio Craveiro Switzerland 8 187 0.9× 72 0.4× 21 0.2× 61 0.8× 4 0.1× 27 258
James Simsarian United States 9 185 0.9× 68 0.4× 14 0.1× 62 0.8× 17 0.6× 13 316
Joela Mathews United Kingdom 8 164 0.8× 25 0.2× 37 0.3× 59 0.8× 4 0.1× 21 220
Teresa Olivé Spain 9 39 0.2× 18 0.1× 89 0.8× 40 0.5× 16 0.6× 16 301
Lauren Chad Canada 9 20 0.1× 63 0.4× 38 0.3× 24 0.3× 3 0.1× 28 287
Muriel Sadlier Ireland 5 42 0.2× 136 0.8× 23 0.2× 10 0.1× 4 0.1× 17 233
Daniel J. M. Crouch United Kingdom 8 22 0.1× 42 0.3× 29 0.3× 31 0.4× 5 0.2× 21 367

Countries citing papers authored by Birte Elias-Hamp

Since Specialization
Citations

This map shows the geographic impact of Birte Elias-Hamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birte Elias-Hamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birte Elias-Hamp more than expected).

Fields of papers citing papers by Birte Elias-Hamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birte Elias-Hamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birte Elias-Hamp. The network helps show where Birte Elias-Hamp may publish in the future.

Co-authorship network of co-authors of Birte Elias-Hamp

This figure shows the co-authorship network connecting the top 25 collaborators of Birte Elias-Hamp. A scholar is included among the top collaborators of Birte Elias-Hamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birte Elias-Hamp. Birte Elias-Hamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Konen, Franz Felix, Steffen Pfeuffer, Klaus Gehring, et al.. (2025). Switching from anti-CD20 therapies to cladribine and vice versa – Analysis of a German relapsing multiple sclerosis cohort. Neurotherapeutics. 23(1). e00812–e00812.
2.
Hellwig, Kerstin, Philipp Franken, Birte Elias-Hamp, et al.. (2025). Vaccination coverage and its determinants in patients with multiple sclerosis—a multicenter cross-sectional study. Therapeutic Advances in Neurological Disorders. 18. 4233590894–4233590894.
3.
Zettl, Uwe K., Paulus Rommer, Orhan Aktaş, et al.. (2023). Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation. Expert Review of Clinical Immunology. 19(11). 1343–1359. 4 indexed citations
4.
Bove, Riley, Maria K. Houtchens, Birte Elias-Hamp, et al.. (2021). Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review. Frontiers in Neurology. 12. 554375–554375. 33 indexed citations
5.
Stangel, Martin, V. Becker, Birte Elias-Hamp, et al.. (2021). Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets – expert opinion on issues in clinical practice. Multiple Sclerosis and Related Disorders. 54. 103075–103075. 3 indexed citations
6.
Gold, Ralf, Eugen Schlegel, Birte Elias-Hamp, et al.. (2018). Incidence and mitigation of gastrointestinal events in patients with relapsing–remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE). Therapeutic Advances in Neurological Disorders. 11. 1276990343–1276990343. 19 indexed citations
7.
Stürner, Klarissa Hanja, V. Becker, Birte Elias-Hamp, et al.. (2017). Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS. Neurology Neuroimmunology & Neuroinflammation. 4(2). e325–e325. 18 indexed citations
8.
Hellwig, Kerstin, Sandra Herbstritt, Nadja Borisow, et al.. (2015). Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses. JAMA Neurology. 72(10). 1132–1132. 100 indexed citations
9.
Haghikia, Aiden, Annette Langer‐Gould, Georg Rellensmann, et al.. (2014). Natalizumab Use During the Third Trimester of Pregnancy. JAMA Neurology. 71(7). 891–891. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurice Dahdaleh Breakdown of academic impact, for papers by Ai‐Lan Nguyen Breakdown of academic impact, for papers by Hanna Joensen Breakdown of academic impact, for papers by Licínio Craveiro Breakdown of academic impact, for papers by James Simsarian Breakdown of academic impact, for papers by Joela Mathews Breakdown of academic impact, for papers by Teresa Olivé Breakdown of academic impact, for papers by Lauren Chad Breakdown of academic impact, for papers by Muriel Sadlier Breakdown of academic impact, for papers by Daniel J. M. Crouch
Rankless by CCL
2026